Wells Fargo’s enVVeno Medical NVNO Stock Holding History

Wells Fargo’s Portfolio NVNO Stock Details NVNO Fund Activity

Bought

Maintained

Sold

Quarter	Market Value	Status	Shares	Change in Stake	Trade Value	Portfolio Weight	Portfolio Position
2026 Q2	$1.22K	Hold	114	–	–	﹤0.01%	6430
2026 Q1	$1.16K	Buy	114 +57	+100%	+$624	﹤0.01%	6322
2025 Q4	$642	Hold	57	–	–	﹤0.01%	6315
2025 Q3	$1.81K	Hold	57	–	–	﹤0.01%	6195
2025 Q2	$7.98K	Hold	57	–	–	﹤0.01%	6003
2025 Q1	$5.26K	Hold	57	–	–	﹤0.01%	6015
2024 Q4	$6.04K	Hold	57	–	–	﹤0.01%	6031
2024 Q3	$6.72K	Hold	57	–	–	﹤0.01%	5870
2024 Q2	$10.5K	Sell	57 -3	-5%	-$524	﹤0.01%	5728
2024 Q1	$11.4K	Hold	60	–	–	﹤0.01%	5728
2023 Q4	$10.8K	Buy	60 +1	+2%	+$159	﹤0.01%	5823
2023 Q3	$11.1K	Hold	59	–	–	﹤0.01%	5783
2023 Q2	$6.35K	Hold	59	–	–	﹤0.01%	6033
2023 Q1	$9.64K	Hold	59	–	–	﹤0.01%	5871
2022 Q4	$10.5K	Hold	59	–	–	﹤0.01%	5534
2022 Q3	$13K	Hold	59	–	–	﹤0.01%	5586
2022 Q2	$8K	Buy	59 +1	+2%	+$155	﹤0.01%	5846
2022 Q1	$13K	Hold	58	–	–	﹤0.01%	6177
2021 Q4	$13K	Buy	58 +28	+93%	+$7.88K	﹤0.01%	6459
2021 Q3	$10K	Hold	30	–	–	﹤0.01%	6204
2021 Q2	$7K	Buy	30 +29	+2,900%	+$6.23K	﹤0.01%	6243
2021 Q1	$0	Buy	+1	New	+$278	﹤0.01%	7222
2020 Q4	–	Hold	0	–	–	–	6842
2020 Q3	–	Hold	0	–	–	–	6715
2020 Q2	–	Hold	0	–	–	–	6648
2020 Q1	–	Hold	0	–	–	–	6605

Other funds holding NVNO

KCM

Kingdon Capital Management New York $976M AUM 66.76% 1-Year Est. Return

CM Management Gulf Breeze, Florida $157M AUM 60.08% 1-Year Est. Return

Vanguard Capital Management Malvern, Pennsylvania $4.68T AUM

JP Morgan Chase New York $1.81T AUM 41.13% 1-Year Est. Return

Vanguard Fiduciary Trust Malvern, Pennsylvania $454B AUM

WIM

Westside Investment Management Santa Monica, California $761M AUM 39.85% 1-Year Est. Return

Mirae Asset Global Investments Seoul, South Korea $67.7B AUM 57.61% 1-Year Est. Return

BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return

TRCT

Tower Research Capital (TRC) New York $4.08B AUM 58.77% 1-Year Est. Return

APW

Allied Private Wealth Boca Raton, Florida $156M AUM

Wells Fargo's NVNO Position: Q2 2026 in Review

Wells Fargo held its enVVeno Medical (NVNO) position steady in Q2 2026 at 114 shares worth $1.22K. The position accounts for ﹤0.01% of the portfolio, ranked #6430.

Wells Fargo first reported a position in NVNO in Q1 2021 and has held it in 22 quarters since. The position peaked at $13K in Q3 2022. 17 funds tracked by Wall St. Rank hold NVNO as of Q2 2026.

Wells Fargo held 114 shares of enVVeno Medical worth $1.22K as of Q2 2026.
Wells Fargo left its enVVeno Medical share count unchanged in Q2 2026.
enVVeno Medical made up ﹤0.01% of Wells Fargo's portfolio in Q2 2026, its #6430 holding.
Wells Fargo first reported a position in enVVeno Medical in Q1 2021 and has held it in 22 quarters since.
Wells Fargo's enVVeno Medical position peaked at $13K in Q3 2022.
17 funds tracked by Wall St. Rank held enVVeno Medical as of Q2 2026.

Based on Wells Fargo's 13F filing for Q2 2026, filed 14 Aug 2026.